Literature DB >> 6087318

Monoclonal antibodies to purified muscarinic receptor display agonist-like activity.

D Leiber, S Harbon, J G Guillet, C André, A D Strosberg.   

Abstract

Monoclonal antibody M-35, which immunoprecipitates native calf brain acetylcholine muscarinic receptor, mimics agonist stimulation of the intact guinea pig myometrium: the antibody, just like carbamoylcholine hydrochloride, causes a rise in intracellular cyclic GMP content, an inhibition of cyclic AMP accumulation due to prostacyclin, and induces uterine contractions. Another antibody, M-23, which reacts with the denatured muscarinic receptor, is devoid of agonist-like activity at the cyclic nucleotide level but is still able to induce contractions of both rat and guinea pig myometrium. The cyclic nucleotide changes caused by both carbamoylcholine and antibody M-35 are inhibited by atropine; this antagonist, which blocks carbamoylcholine-mediated contractions, fails however, to prevent contractions induced by antibodies M-35 and M-23. These results suggest that the information necessary to transmit muscarinic signals is entirely contained in the receptor and that ligands only act to trigger the biological response. The data also imply that the muscarinic receptors of the myometrium are coupled to multiple effector systems.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087318      PMCID: PMC345582          DOI: 10.1073/pnas.81.14.4331

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Guanosine 3', 5'-cyclicmonophosphate assay at 10(-15)-mole level.

Authors:  H L Cailla; C J Vannier; M A Delaage
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

2.  Prostacyclin as an endogenous modulator of adenosine cyclic 3',5'-monophosphate levels in rat myometrium and endometrium.

Authors:  M F Vesin; L D Khac; S Harbon
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

3.  Role of cyclic nucleotides in control of smooth muscle contraction.

Authors:  J Diamond
Journal:  Adv Cyclic Nucleotide Res       Date:  1978

Review 4.  Cyclic GMP metabolism and involvement in biological regulation.

Authors:  N D Goldberg; M K Haddox
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

5.  Stereospecific in vitro binding of [3H]dexetimide to brain muscarinic receptors.

Authors:  P M Laduron; M Verwimp; J E Leysen
Journal:  J Neurochem       Date:  1979-02       Impact factor: 5.372

6.  "Antibodies raised against beta-adrenergic receptors stimulate adenylate cyclase".

Authors:  P O Couraud; C Delavier-Klutchko; O Durieu-Trautmann; A D Strosberg
Journal:  Biochem Biophys Res Commun       Date:  1981-04-30       Impact factor: 3.575

7.  Modulation of the binding properties of muscarinic receptors: evidence for receptor-effector coupling.

Authors:  N J Birdsall; C P Berrie; A S Burgen; E C Hulme
Journal:  Adv Biochem Psychopharmacol       Date:  1980

8.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

Review 9.  Insulin receptors, receptor antibodies, and the mechanism of insulin action.

Authors:  C R Kahn; K L Baird; J S Flier; C Grunfeld; J T Harmon; L C Harrison; F A Karlsson; M Kasuga; G L King; U C Lang; J M Podskalny; E Van Obberghen
Journal:  Recent Prog Horm Res       Date:  1981

10.  Properties of acetylcholine receptors translated by cat muscle mRNA in Xenopus oocytes.

Authors:  R Miledi; I Parker; K Sumikawa
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  11 in total

1.  Immunocytochemical localization of muscarinic acetylcholine receptors in the rat endocrine pancreas.

Authors:  E A Van der Zee; B Buwalda; J H Strubbe; A D Strosberg; P G Luiten
Journal:  Cell Tissue Res       Date:  1992-07       Impact factor: 5.249

Review 2.  Immunohistochemistry of cholinergic receptors.

Authors:  H Schröder
Journal:  Anat Embryol (Berl)       Date:  1992-10

3.  Demonstration of muscarinic acetylcholine receptor-like immunoreactivity in the rat forebrain and upper brainstem.

Authors:  E A van der Zee; T Matsuyama; A D Strosberg; J Traber; P G Luiten
Journal:  Histochemistry       Date:  1989

Review 4.  Immunocytochemical applications in neuroanatomy. Demonstration of connections, transmitters and receptors.

Authors:  P G Luiten; F G Wouterlood; T Matsuyama; A D Strosberg; B Buwalda; R P Gaykema
Journal:  Histochemistry       Date:  1988

5.  Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody.

Authors:  M Halbach; V Hömberg; H J Freund
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

Review 6.  Next generation antibody drugs: pursuit of the 'high-hanging fruit'.

Authors:  Paul J Carter; Greg A Lazar
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

7.  Muscarinic control of cytoskeleton in perisynaptic glia.

Authors:  J Georgiou; R Robitaille; M P Charlton
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

8.  Fluoroaluminates mimic muscarinic- and oxytocin-receptor-mediated generation of inositol phosphates and contraction in the intact guinea-pig myometrium. Role for a pertussis/cholera-toxin-insensitive G protein.

Authors:  S Marc; D Leiber; S Harbon
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

9.  Muscarinic receptors in the prenatal mouse embryo. Comparison of M35-immunohistochemistry with [3H]quinuclidinyl benzylate autoradiography.

Authors:  M Lammerding-Köppel; A Greiner-Schröder; U Drews
Journal:  Histochem Cell Biol       Date:  1995-04       Impact factor: 4.304

10.  Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus.

Authors:  F Dörje; T Friebe; R Tacke; E Mutschler; G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.